Unusual volume stocks are being observed in Wednesday's session. The trading volume of these stocks is deviating from the norm in today's session.
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via Phase 3 trials.
DRRX Stock Earnings: Durect Beats EPS, Misses Revenue for Q2 2024 DRRX stock results show that Durect beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
DRRX Stock Earnings: Durect Misses EPS, Misses Revenue for Q1 2024 DRRX stock results show that Durect missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
DRRX Stock Earnings: Durect Beats EPS, Beats Revenue for Q4 2023 DRRX stock results show that Durect beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Top 3 Health Care Stocks That Are Preparing To Pump This Month The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Earnings Scheduled For March 27, 2024 Companies Reporting Before The Bell • Local Bounti (
NYSE:LOCL ) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
Earnings Scheduled For November 13, 2023 Companies Reporting Before The Bell • Sohu.com (
NASDAQ:SOHU ) is expected to report earnings for its third quarter. • Dixie Gr (
NASDAQ:DXYN ) is estimated to report earnings for its third quarter.
